Pregledni rad

Update on Antithrombotic Agents in Secondary Stroke Prevention

Tatjana Rundek ; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA
Vanja Bašić-Kes ; University Department of Neurology, Reference Center for Neurovascular Disorders and Headache of the Ministry of Health and Social Welfare, Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Sandra Morović ; University Department of Neurology, Reference Center for Neurovascular Disorders and Headache of the Ministry of Health and Social Welfare, Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Vida Demarin ; University Department of Neurology, Reference Center for Neurovascular Disorders and Headache of the Ministry of Health and Social Welfare, Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia

Sažetak

Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

Ključne riječi

Stroke - prevention and control; Secondary prevention; Platelet aggregation inhibitors - therapeutic use; Anticoagulants

Hrčak ID:

77627

URI

https://hrcak.srce.hr/77627

Datum izdavanja:

31.3.2011.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.927 *